Over 2,400 attendees from 31 countries gathered in Philadelphia for the 2018 ISPE Annual Meeting & Expo. The opening plenary on Sunday, 4 November provided a strong kickoff to the four-day conference, whose theme of “Vision to Reality” focused on the promise of new developments that ISPE members are helping the pharmaceutical industry tackle.
Lars Fruegaard Jørgensen, President and CEO of Novo Nordisk A/S and Honorary Conference Chair, gave a presentation exemplifying the spirit of Vision to Reality by describing the company’s path to a groundbreaking new treatment for patients with diabetes.
Becky Furuta, Ambassador, Team Novo Nordisk and Health Care Policy Consultant, gave the final plenary presentation on “How Diabetes Drives My Success.” She shared her story about how bike racing was a way to cope with and escape a youth challenged by family illness and poverty to build strength and self-reliance.
The second day of the 2018 ISPE Annual Meeting & Expo on Monday, 5 November opened on a note of innovation and energy. “There’s a tremendous amount of energy here,” James Breen, Jr., Incoming Chair of the ISPE International Board of Directors, told attendees as he opened the morning plenary. “I want to keep the momentum going.”
The first plenary session speaker, Nick Leschly, CEO of Massachusetts-based bluebird bio, shared the story of bluebird bio’s birth and progress as he spoke with humor and passion about gene therapy.
Each year during the ISPE Annual Meeting & Expo, the ISPE International Honor Awards Committee acknowledges exceptional efforts, recognizing individual volunteers, affiliates and chapters, students, the company of the year, and the Facility of the Year Awards (FOYA) Overall Winner.
View the slideshow below of images from the 2018 ISPE Annual Meeting & Expo Membership & Awards Breakfast
Regulators from three global agencies—US FDA, MHRA, and Brazil’s ANVISA—discussed how their agencies are addressing emerging therapies during the “Global Regulatory Town Hall”